Condition 1: Behavior Control at the Dental Clinics. Condition 2: Uncooperative behavior in dental clinic. Behavioural syndromes associated with physiological disturbances and physical factors
Conditions
Interventions
Intervention 1: Chloral Hydrate (50 mg/kg) /Hydroxyzine (1 mg/kg) both suspension form were given to children of the case group (oral mode), 1/2 hour before treatment start along with full monitoring
Treatment - Drugs
Chloral Hydrate (50 mg/kg) /Hydroxyzine (1 mg/kg) both suspension form were given to children of the case group (oral mode), 1/2 hour before treatment start along with full monitoring the vital signs
Oral suspension of Midazolam(0.5 mg/kg) along side Hydroxyzine elexir (1mg/kg)was administered in Control session 30 minutes prior to the starting point of the dental treatment in one dose. All vital
Sponsors
Iran Center for Dental Research, Shahid Beheshti Medical University
Eligibility
Sex/Gender
All
Age
6 Years to 10 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: cases with a behavioral score of 2 in Frankel scale system (Uncooperative); those with at least two similar dental needs; ages of 6-10 years old; able to attend two visits scheduled for dental treatments; able to keep 4 hours NPO prior to sedation. Exclusion criteria: clear from any medical condition (out of the ASA I & II); taking any sedative, narcotic or CNS depressant drug; those who have cold or other respiratory obstruction; those having fever of known or unknown origin; unable to observe 4 hours of NPO; unable to accept the drugs administered due to taste or volume.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessing the success rate in child management. Timepoint: Exactly after the operation ends. Method of measurement: Behavior Assessment indices.;Child cooperation for Dental treatment delivery. Timepoint: Immidiately after the treatment end. Method of measurement: Judged by independent pediatric dentist and the operator. | — |
Secondary
| Measure | Time frame |
|---|---|
| Potential side effects of the drugs. Timepoint: End of1st year of the study. Method of measurement: Questionnaire and behavioral scales.;Assessing the success rate in each group. Timepoint: Half way assessments of the collected data. Method of measurement: Employing behavioral rating scales available. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhassem Ansari
Shahid Beheshti Medical University
Outcome results
None listed